antigen peptide-specific DC-CTL cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for antigen peptide-specific DC-CTL cells, covering 2020-12-17 to 2020-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine [Phase 1, Phase 2]